Ergometric exercise testing and sensitivity of cyclic guanosine 3',5'-monophosphate (cGMP) in diagnosing asymptomatic left ventricular dysfunction.
OBJECTIVE--Increased plasma concentrations of cyclic guanosine monophosphate (cGMP) have been reported in patients with manifest heart failure. At rest, however, cGMP concentrations in patients with asymptomatic left ventricular dysfunction or heart failure in New York Heart Association (NYHA) funct...
Guardado en:
| Publicado en: | Br Heart J |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
1995
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC483781/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7696024/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/hrt.73.2.145 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|